A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 395 participants.

Also called NCT04562142

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 395 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04562142
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04562142. Allocation not applicable; no masking; primary purpose other. Start 2021-03 (anticipated); primary completion 2022-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study
Condition
Cardiovascular Diseases
Condition
Atherosclerosis
Condition
Coronary Occlusion
Intervention (Device)
CAD-det
Lead sponsor
AusculSciences Canada Inc. (class: industry)
Collaborator
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct04562142
Content hash
6b66179781324f7b4dd3617e2322f73798b8c2ec6a1dc41f3242eccac60e49c9